The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.

作者： B T Colvin , T W Barrowcliffe

DOI: 10.1136/JCP.46.2.97

关键词:

摘要:

参考文章(37)

J Van Ryn-McKenna, L Cai, F A Ofosu, J Hirsh, M R Buchanan, Neutralization of enoxaparine-induced bleeding by protamine sulfate. Thrombosis and Haemostasis. ,vol. 63, pp. 271- 274 ,(1990) , 10.1055/S-0038-1645207

Curtis, Ireland H, Lane Da, Objective assessment of heparin requirements for hemodialysis in humans. Journal of Laboratory and Clinical Medicine. ,vol. 103, pp. 643- ,(1984)

Rory Collins, Alison Scrimgeour, Salim Yusuf, Richard Peto, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. The New England Journal of Medicine. ,vol. 318, pp. 1162- 1173 ,(1988) , 10.1056/NEJM198805053181805

T W Barrowcliffe, A D Curtis, E A Johnson, D P Thomas, An international standard for low molecular weight heparin. Thrombosis and Haemostasis. ,vol. 60, pp. 1- 7 ,(1988) , 10.1055/S-0038-1647623

D. A. Lane, Ulf Lindahl, Heparin : chemical and biological properties, clinical applications Edward Arnold. ,(1989)

B.S.K. KAMATH, J.R. FOZARD, Control of heparinisation during cardiopulmonary bypass. Experience with the activated clotting time method. Anaesthesia. ,vol. 35, pp. 250- 256 ,(1980) , 10.1111/J.1365-2044.1980.TB05092.X

L. Poller, C. A. Ludlam, Recent Advances in Blood Coagulation ,(1994)

J. F. KEELER, M. V. SHAH, S. D. HANSBRO, Protamine--the need to determine the dose. Comparison of a simple protamine titration method with an empirical dose regimen for reversal of heparinisation following cardiopulmonary bypass. Anaesthesia. ,vol. 46, pp. 925- 928 ,(1991) , 10.1111/J.1365-2044.1991.TB09848.X

Elizabeth A. Letsky, Coagulation Problems During Pregnancy ,(1985)

D A Lane, J Denton, A M Flynn, L Thunberg, U Lindahl, Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. Biochemical Journal. ,vol. 218, pp. 725- 732 ,(1984) , 10.1042/BJ2180725